Cheng Andrew
- SEC CIK
- 0001778307
In the past year, 1 open-market sale filing worth $1.62M and no purchases.
Current role at each company
- DMRA Damora Therapeutics, Inc.Directoras of Aug 13, 2026
- VERA Vera Therapeutics, Inc.Directoras of May 26, 2026
- AKRO Akero Therapeutics, Inc.President and CEOas of Dec 9, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $1.62M
- 1 filing
- Net
- −$1.62M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Cheng Andrew as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
AKRO Akero Therapeutics, Inc.
President and CEO47 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 6, 2021 (view filing) | Jul 2 | 4 days | Cheng AndrewPresident & CEO | SSale | −17.5K | $24.78 | −$433.6K | −4.9%342.5K after | |
| Aug 4, 2021 (view filing) | Aug 3 | 1 day | Cheng AndrewPresident & CEO | SSale | −17.5K | $20.83 | −$364.6K | −5.1%326.0K after | 2 lots |
| Sep 3, 2021 (view filing) | Sep 2 | 1 day | Cheng AndrewPresident & CEO | SSale | −17.5K | $23.89 | −$418.1K | −5.4%308.5K after | |
| Oct 5, 2021 (view filing) | Oct 4 | 1 day | Cheng AndrewPresident & CEO | SSale | −17.5K | $21.54 | −$376.9K | −5.7%291.0K after | |
| Nov 3, 2021 (view filing) | Nov 2 | 1 day | Cheng AndrewPresident & CEO | SSale | −17.5K | $22.57 | −$395.0K | −6.0%273.5K after | |
| Dec 3, 2021 (view filing) | Dec 2 | 1 day | Cheng AndrewPresident & CEO | SSale | −17.5K | $20.18 | −$353.1K | −6.4%256.0K after | |
| Jan 11, 2022 (view filing) | Jan 10, 2021 | 366 days | Cheng AndrewPresident & CEO | SSale | −10.0K | $19.55 | −$195.5K | −3.2%299.0K after | From original |
| Feb 3, 2022 (view filing) | Feb 1 | 2 days | Cheng AndrewPresident & CEO | SSale | −10.0K | $17.56 | −$175.6K | −3.1%309.0K after | |
| Mar 2, 2022 (view filing) | Mar 1 | 1 day | Cheng AndrewPresident & CEO | SSale | −10.0K | $17.59 | −$175.9K | −3.1%309.0K after | |
| Sep 15, 2022 (view filing) | Sep 13 | 2 days | Cheng AndrewPresident & CEO | SSale | −60.0K | $27.42 | −$1.65M | −16.2%310.1K after | 2 lots |